Find clinical trials for Lung Cancer in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Rochester, MN, USA:
The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) exp....
Phase 2
Rochester, Minnesota, United States and 9 other locations
to evaluate the safety and efficacy of abenacianine for injection, a tumor-targeted, activatable fluorescent imaging agent, to identify cancer...
Phase 3
Rochester, Minnesota, United States and 5 other locations
with advanced/metastatic or relapsed/progressive small cell lung cancer (SCLC) and non small cell lung cancer (NS...
Phase 1, Phase 2
Rochester, Minnesota, United States and 57 other locations
in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung...
Phase 1, Phase 2
Rochester, Minnesota, United States and 58 other locations
This study evaluates the use of SMS001 in patients with lung cancer. SMS001 is a new form of drug Paclitaxel. Doctors want to decid ...
Phase 2
Rochester, Minnesota, United States and 1 other location
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...
Phase 3
Rochester, Minnesota, United States and 300 other locations
and antitumor activity of silevertinib (BDTX-1535). The study population comprises adults with either advanced/metastatic non-small cell lung...
Phase 1, Phase 2
Rochester, Minnesota, United States and 28 other locations
to better understand best doses for patients with small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC) of ...
Phase 1
Rochester, Minnesota, United States and 11 other locations
combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small cell lung ...
Phase 1
Rochester, Minnesota, United States and 71 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small Cell Lung...
Phase 1, Phase 2
Rochester, Minnesota, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal